Richard Neubig, M.D., Ph.D.,

Richard NeubigRichard Neubig, M.D., Ph.D., is Chair and Professor at Pharmacology & Toxicology at Michigan State University. His research interests include G protein-coupled receptor (GPCR) signaling and intracellular modulators of that signaling. GPCRs are the targets of over 25% of current drugs and we are discovering novel ways to control their function. His lab also undertakes academic drug discovery projects in this area. He has served as Co-Director of the Center for Chemical Genomics at the University of Michigan, was the founding Chair of the Molecular Pharmacology Division of ASPET, and recently served as ASPET President. He has served on numerous editorial boards and study sections and has received several awards, including the ASPET-Astellas Award in Translational Pharmacology, in 2009 and the Pharmacia-ASPET Award for Experimental Therapeutics, in 2013. In 2015, he was named as AAAS fellow for “pioneering work on the quantitative analysis of receptor mechanisms, particularly concerning regulators of G protein signaling, molecular switches within cells, and for insightful leadership in the pharmacological sciences.”